Additionally, knockdown of ZNF252P-AS1 inhibited ovarian cancer tumor growth in vivo, as indicated by the decreased tumor volume and tumor weight, which further indicated that ZNF252P-AS1 might act as a promoter in ovarian cancer progression. The gene discussed is ZNF252P; the disease is ovarian cancer.